Xeris Biopharma: HC Wainwright raises Buy rating, PT to $10.

Friday, Jan 9, 2026 8:33 am ET1min read
XERS--

Xeris Biopharma: HC Wainwright raises Buy rating, PT to $10.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet